BiotechTubeBiotechTube
Home/Immunovant/Eric Venker, MD, PharmD
EV

Eric Venker, MD, PharmD

Chief Executive Officer

Immunovant

Therapeutic Areas

Autoimmune DiseasesImmunology

Immunovant Pipeline

DrugIndicationPhase
BatoclimabIgG-mediated autoimmune diseasesPhase 2b/3
IMVT-1402IgG-mediated autoimmune diseasesPhase 1

Leadership Team at Immunovant

CB
Christine Blodgett
Senior Vice President of Human Resources
KG
Khira Gabliani, MBA
Chief of Staff to the CEO
TG
Tiago Girão
Chief Financial Officer
MG
Melanie Gloria, BSN
Chief Operating Officer
View full Immunovant profile